Published in Rev Clin Esp on December 15, 1980
[Effectiveness of pre-emptive hemodialysis with high-flux membranes for the treatment of life-threatening alcohol poisoning]. Nefrologia (2008) 1.51
[Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies]. An Med Interna (2001) 1.39
[Developing a Clinical Performance Measures System for hemodialysis, Quality Group, Spanish Society of Nephrology]. Nefrologia (2007) 1.39
Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology (2000) 1.38
[Nephropathia caused by hantavirus puumala: a case report]. Nefrologia (2005) 1.38
Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol (2000) 1.36
Changes in quality of life after renal transplantation. Am J Kidney Dis (1998) 1.31
New fossil materials of the earliest new world monkey, Branisella boliviana, and the problem of platyrrhine origins. Am J Phys Anthropol (2000) 1.22
Quality of life in dialysis patients. A spanish multicentre study. Spanish Cooperative Renal Patients Quality of Life Study Group. Nephrol Dial Transplant (1996) 1.09
[Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multicenter study in Spain]. Nefrologia (2002) 1.06
Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron (1998) 1.05
Nephrologists of the Balkan countries meet across political frontiers and war fronts--an example to politicians! BANTAO: a new European medical association overcomes political obstacles. Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs. Nephrol Dial Transplant (1996) 1.05
Renal artery stenosis after kidney transplantation: diagnostic and therapeutic approach. Kidney Int Suppl (1998) 1.02
High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis (1990) 0.99
Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study. AIDS Res Hum Retroviruses (2008) 0.98
Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells. J Neuroimmunol (1995) 0.98
Report on management of renal failure in Europe, XXV, 1994. The child-adult interface. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association. Nephrol Dial Transplant (1996) 0.98
[Visceral leishmaniasis in systemic lupus erythematosus]. Med Clin (Barc) (1987) 0.92
Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis. Nephrol Dial Transplant (2001) 0.91
Disentangling the role of the tau gene locus in sporadic tauopathies. Curr Alzheimer Res (2010) 0.91
Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis. Transplant Proc (2009) 0.90
Why and how to monitor bacterial contamination of dialysate? Nephrol Dial Transplant (2000) 0.90
Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association. Nephrol Dial Transplant (1996) 0.90
Renal vascular disease in the elderly. Kidney Int Suppl (1998) 0.90
Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Am J Kidney Dis (1996) 0.89
European best practice guidelines 14-16: inadequate response to epoetin. Nephrol Dial Transplant (2000) 0.89
European best practice guidelines 6-8: assessing and optimizing iron stores. Nephrol Dial Transplant (2000) 0.88
Progress in dialysis technology: membrane selection and patient outcome. Nephrol Dial Transplant (2000) 0.88
Reduction of metmyoglobin derivatives by dithionite ion. J Biol Chem (1977) 0.88
European best practice guidelines 1-4: evaluating anaemia and initiating treatment. Nephrol Dial Transplant (2000) 0.87
New specimens of the oldest fossil platyrrhine, Branisella boliviana, from Salla, Bolivia. Am J Phys Anthropol (1996) 0.86
Development of systemic lupus erythematosus in a patient on hemodialysis. Am J Nephrol (1992) 0.85
Report on management of renale failure in Europe, XXVI, 1995. The child-adult interface: a report on Alport's syndrome, 1975-1993. The ERA-EDTA Registry. Nephrol Dial Transplant (1996) 0.85
Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant (1995) 0.85
Treatment of acute antibody-mediated rejection: a single-center experience. Transplant Proc (2010) 0.85
[Influence of early or late referral to nephrologist over morbidity and mortality in hemodialysis]. Nefrologia (2003) 0.84
Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. J Med Virol (2001) 0.84
Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review. Transplantation (1998) 0.84
[Differences in health-related quality of life between male and female hemodialysis patients]. Nefrologia (2004) 0.84
European best practice guidelines 5: target haemoglobin. Nephrol Dial Transplant (2000) 0.83
[Clinical and analytical changes in hemodialysis without acetate]. Nefrologia (2007) 0.81
[Recovery of renal function in patients in a dialysis program]. Nefrologia (2002) 0.81
Short daily versus conventional hemodialysis quality of life: a cross-sectional multicentric study in Spain. Blood Purif (2009) 0.81
Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine. Transplant Proc (2007) 0.80
Comparisons of hemodialysis and CAPD in patients over 65 years of age: a meta-analysis. Int Urol Nephrol (2001) 0.80
Prevalence of hypertension in renal disease. Nephrol Dial Transplant (2001) 0.79
Effects of antihypertensive therapy on progression of diabetic nephropathy. Kidney Int Suppl (1998) 0.79
Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena. Proc Eur Dial Transplant Assoc (1983) 0.79
Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection. Aliment Pharmacol Ther (2009) 0.78
Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years. Transplant Proc (2006) 0.78
Haemodialysis dose, extracellular volume control and arterial hypertension. Nephrol Dial Transplant (2001) 0.78
[Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses]. Rev Neurol (2000) 0.78
Transfusion-induced anergy: skin test as an index for pretransplant transfusions. Proc Eur Dial Transplant Assoc (1983) 0.78
[Guidelines for indicating, obtaining, processing and evaluating kidney biopsies]. Nefrologia (2008) 0.78
Anemia associated with pegylated interferon-alpha2a and alpha2b therapy in hemodialysis patients. Clin Nephrol (2007) 0.77
Effects of L-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophospholipid acyltransferase in uremia. Am J Clin Nutr (1998) 0.77
[Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey]. Nefrologia (2008) 0.77
High-sensitivity troponin T levels in kidney transplant recipients. Transplant Proc (2012) 0.77
A subset of splenic macrophages process and present native antigen to naive antigen-specific CD4+ T-cells from mice transgenic for an alpha beta T-cell receptor. Cell Immunol (1995) 0.76
[Dialysis inclusion criteria and early mortality]. Nefrologia (2001) 0.76
[Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?]. Nefrologia (2001) 0.76
Monitoring of circulating antibodies in a renal transplantation population: preliminary results. Transplant Proc (2012) 0.76
Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients. Transplant Proc (2008) 0.76
Renal failure in temporal arteritis. Am J Nephrol (1992) 0.75
Transplantation Report. 1: renal transplantation in recipients aged 60 years or older at time of grafting. The EDTA-ERA Registry. European Dialysis and transplant Association-European Renal Association. Nephrol Dial Transplant (1996) 0.75
Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative. Am J Nephrol (1998) 0.75
[The essential role of water treatment system (WTS) in the qualify of water for hemodialysis]. Nefrologia (2008) 0.75
Evaluation of oxidant-antioxidant balance in patients on maintenance haemodialysis: a comparative study of dialyzers membranes. Nephron Clin Pract (2009) 0.75
Is the development of 'de novo' allograft membranes nephropathy linked to ureteric obstruction? Nephrol Dial Transplant (1993) 0.75
Neonatal kidney grafts into adult recipients. Nephron (1991) 0.75
[Preliminary results of the Spanish Society of Nephrology multicenter study of quality performance measures: hemodialysis outcomes can be improved]. Nefrologia (2008) 0.75
Outcome of acute renal failure in the elderly: a different approach. Nephrol Dial Transplant (1996) 0.75
Membranoproliferative glomerulonephritis and hepatitis C virus infection. Nephron (1994) 0.75
Minimal change glomerular disease in association with a carcinoma of the esophagus. Nephron (1994) 0.75
L-Carnitine in dialysis, more than a commercial affair. Nephrol Dial Transplant (2000) 0.75
[Cryptosporidium parvum infection in a kidney transplant recipient]. Nefrologia (2010) 0.75
Plasma exchange in the treatment of vascular rejection. Relationship between histological changes and therapeutic response. Transplant Proc (1987) 0.75
Anaphylactoid reactions during hemodialysis on AN69 membranes: role of ACE inhibitors and back-filtration. Nephron (1992) 0.75
Sequential therapy with anti-thymocyte globulin and cyclosporine A in oligoanuric high-risk cadaveric kidney graft recipients. Transplant Proc (1988) 0.75
[Reconsideration of plasmapheresis treatment of renal post-transplant recurrence of segmental and focal hyalinosis]. Med Clin (Barc) (1987) 0.75
[Association of papulous mucinosis and systemic lupus erythematosus with membranous glomerulonephritis]. Rev Clin Esp (1980) 0.75
[Tansitional vesical cell carcinoma metastatizing to the sphenoid sinus]. Acta Otorrinolaringol Esp (2006) 0.75
[Renal post-transplant recurrence of segmental and focal hyalinosis. Its treatment with plasmapheresis]. Med Clin (Barc) (1986) 0.75
[Prevention of cardiovascular risk in renal transplantation. Consensus document]. Nefrologia (2002) 0.75
Symptomatic pneumoperitoneum after bilateral laparoscopic nephrectomy in a renal transplant patient. Am J Nephrol (1997) 0.75
[Monitoring dermatomal somatosensory evoked potentials at the ERB point, the cervical spinal cord and the cerebral cortex in the diagnosis of cervical radiculopathy]. Rev Neurol (2003) 0.75
Spontaneous remission of proteinuria in recurrent focal glomerulosclerosis. Reappraisal of plasma exchange treatment. Clin Nephrol (1987) 0.75
[Listeriosis of the central nervous system]. Med Clin (Barc) (1988) 0.75
[Disseminated cryptococosis in renal transplant recipient]. Nefrologia (2005) 0.75
Kidney transplantation with grafts from non-heart-beating donors. Transplant Proc (2006) 0.75
Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation. Nephrol Dial Transplant (2001) 0.75